Literature DB >> 25136875

Do practice settings influence defensive medicine in orthopedic surgery?

Benjamin S Hooe, Rachel V Thakore, Neil Issar, Vasanth Sathiyakumar, William T Obremskey, Manish K Sethi1.   

Abstract

Defensive medicine is often practiced out of fear of legal liability. We conducted a study to compare the costs of defensive medicine among US orthopedic surgeons by practice type and American Medical Association (AMA) state medical liability classification. Two thousand surgeons registered with the American Academy of Orthopaedic Surgeons were sent a survey on defensive medicine. Costs were analyzed using 2011 Centers for Medicare and Medicaid Services data. Of the 2000 surgeons, 1214 (61%) completed the survey. Results showed that defensive tests were ordered by a higher proportion of nonacademic physicians than academic physicians in all 8 categories of orthopedic care, with a mean difference of $2348 in monthly defensive expenditures between groups. A higher rate of defensive testing by orthopedists in AMA crisis states versus safe states was also observed in 6 of the 8 areas of care studied, with mean monthly defensive expenditures ranging from $9208 in crisis states to $6596 in safe states. Defensive orthopedics contributes significantly to health care costs, with marginal benefit to patients-especially in nonacademic and crisis-state orthopedics practices.

Entities:  

Mesh:

Year:  2014        PMID: 25136875

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  2 in total

1.  How defensive medicine is defined and understood in European medical literature: protocol for a systematic review.

Authors:  Nathalie Baungaard; Pia Skovvang; Elisabeth Assing Hvidt; Helle Gerbild; Merethe Kirstine Andersen; Jesper Lykkegaard
Journal:  BMJ Open       Date:  2020-02-28       Impact factor: 2.692

2.  How defensive medicine is defined in European medical literature: a systematic review.

Authors:  Nathalie Baungaard; Pia Ladeby Skovvang; Elisabeth Assing Hvidt; Helle Gerbild; Merethe Kirstine Andersen; Jesper Lykkegaard
Journal:  BMJ Open       Date:  2022-01-20       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.